ConvaTec Group Plc (CNVVF)
USD 2.89
(0.0%)
USD 2.89
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.22 Billion USD | -4.28% |
| 2022 | 1.27 Billion USD | 0.73% |
| 2021 | 1.27 Billion USD | -11.89% |
| 2020 | 1.44 Billion USD | -4.84% |
| 2019 | 1.51 Billion USD | -2.78% |
| 2018 | 1.55 Billion USD | -9.37% |
| 2017 | 1.71 Billion USD | 0.3% |
| 2016 | 1.71 Billion USD | -50.68% |
| 2015 | 3.47 Billion USD | -1.61% |
| 2014 | 3.53 Billion USD | -5.05% |
| 2013 | 3.72 Billion USD | -19.22% |
| 2012 | 4.6 Billion USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.39 Billion USD | 13.38% |
| 2024 Q2 | 1.33 Billion USD | -4.29% |
| 2023 Q4 | 1.22 Billion USD | -5.15% |
| 2023 Q2 | 1.44 Billion USD | 0.0% |
| 2023 Q3 | 1.29 Billion USD | -10.58% |
| 2023 Q1 | 1.44 Billion USD | 12.86% |
| 2023 FY | 1.22 Billion USD | -4.28% |
| 2022 Q3 | 1.28 Billion USD | 0.34% |
| 2022 Q4 | 1.27 Billion USD | -0.02% |
| 2022 FY | 1.27 Billion USD | 0.73% |
| 2022 Q2 | 1.27 Billion USD | 0.0% |
| 2022 Q1 | 1.27 Billion USD | 6.54% |
| 2021 Q2 | 1.35 Billion USD | -5.16% |
| 2021 FY | 1.27 Billion USD | -11.89% |
| 2021 Q4 | 1.19 Billion USD | -5.97% |
| 2021 Q1 | 1.43 Billion USD | 4.65% |
| 2021 Q3 | 1.27 Billion USD | -6.33% |
| 2020 Q2 | 1.44 Billion USD | -4.75% |
| 2020 Q1 | 1.52 Billion USD | 5.21% |
| 2020 Q3 | 1.44 Billion USD | 0.1% |
| 2020 FY | 1.44 Billion USD | -4.84% |
| 2020 Q4 | 1.36 Billion USD | -5.52% |
| 2019 Q3 | 1.51 Billion USD | 0.48% |
| 2019 Q2 | 1.5 Billion USD | -4.26% |
| 2019 FY | 1.51 Billion USD | -2.78% |
| 2019 Q1 | 1.57 Billion USD | -0.4% |
| 2019 Q4 | 1.44 Billion USD | -4.63% |
| 2018 Q3 | 1.58 Billion USD | -5.67% |
| 2018 Q4 | 1.58 Billion USD | 0.0% |
| 2018 FY | 1.55 Billion USD | -9.37% |
| 2018 Q1 | 1.67 Billion USD | -3.9% |
| 2018 Q2 | 1.67 Billion USD | 0.0% |
| 2017 Q3 | 1.74 Billion USD | -0.39% |
| 2017 FY | 1.71 Billion USD | 0.3% |
| 2017 Q1 | 1.75 Billion USD | 0.88% |
| 2017 Q2 | 1.75 Billion USD | -0.04% |
| 2017 Q4 | 1.74 Billion USD | 0.0% |
| 2016 Q2 | 4.03 Billion USD | -1.79% |
| 2016 FY | 1.71 Billion USD | -50.68% |
| 2016 Q4 | 1.73 Billion USD | 0.0% |
| 2016 Q3 | 1.73 Billion USD | -56.91% |
| 2016 Q1 | 4.1 Billion USD | 18.06% |
| 2015 Q2 | 4.04 Billion USD | 2.86% |
| 2015 FY | 3.47 Billion USD | -1.61% |
| 2015 Q3 | 4.05 Billion USD | 0.31% |
| 2015 Q1 | 3.93 Billion USD | -6.68% |
| 2015 Q4 | 3.47 Billion USD | -14.32% |
| 2014 Q3 | 4.37 Billion USD | -6.07% |
| 2014 Q1 | 4.67 Billion USD | 0.13% |
| 2014 FY | 3.53 Billion USD | -5.05% |
| 2014 Q4 | 4.21 Billion USD | -3.61% |
| 2014 Q2 | 4.65 Billion USD | -0.37% |
| 2013 Q2 | 4.56 Billion USD | 1.01% |
| 2013 Q1 | 4.51 Billion USD | -1.92% |
| 2013 Q3 | 5.92 Billion USD | 29.79% |
| 2013 Q4 | 4.66 Billion USD | -21.26% |
| 2013 FY | 3.72 Billion USD | -19.22% |
| 2012 Q4 | 4.6 Billion USD | 0.78% |
| 2012 Q3 | 4.57 Billion USD | 0.0% |
| 2012 FY | 4.6 Billion USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -73.714% |
| Ansell Limited | 706.6 Million USD | -73.389% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -5366.676% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -195926.821% |
| ConvaTec Group Plc | 1.22 Billion USD | 0.141% |
| Encision Inc. | 67.33 Thousand USD | -1819383.833% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -319923.309% |
| LifePoint, Inc. | 151.73 Thousand USD | -807344.366% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -24832.186% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -199114.249% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -680688.625% |
| SmileDirectClub, Inc. | 849.37 Million USD | -44.243% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -481.254% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -2526591.897% |
| Vasamed, Inc. | 18.95 Thousand USD | -6465164.559% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -6633902.783% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -313687.508% |